The role of inflammatory cytokines and NF-κB/MAPK signaling pathways in the evolution of familial Mediterranean fever: Current clinical perspectives and potential therapeutic approaches
- 14 August 2009
- journal article
- review article
- Published by Elsevier in Cellular Immunology
- Vol. 260 (1) , 6-13
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Changing concepts in familial mediterranean fever: Is it possible to have an autosomal‐recessive disease with only one mutation?Arthritis & Rheumatism, 2009
- Familial mediterranean fever with a single MEFV mutation: Where is the second hit?Arthritis & Rheumatism, 2009
- The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragmentBlood, 2008
- TNF receptor-associated periodic syndrome (TRAPS): Description of a novel TNFRSF1A mutation and response to etanerceptEuropean Journal of Pediatrics, 2008
- Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionProceedings of the National Academy of Sciences, 2007
- On the enigma of pain and hyperalgesia: A molecular perspectiveBiochemical and Biophysical Research Communications, 2007
- Possible effect of subclinical inflammation on daily life in familial Mediterranean feverClinical Rheumatology, 2006
- Neutrophil chemotaxis in a patient with neonatal-onset multisystem inflammatory disease and Muckle-Wells syndromeAnnals of Allergy, Asthma & Immunology, 2005
- Serum sIL-2r, IL-6, IL-10 and TNF-? level in familial Mediterranean fever patientsClinical Rheumatology, 2003
- Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. II. Evidence for the Involvement of an Inhibitory-κB/Nuclear Factor-κB-Sensitive Pathway in Alveolar Epithelial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2002